Real-world effectiveness of molnupiravir, nirmatrelvir-ritonavir, and sotrovimab on preventing hospital admission among higher-risk patients with COVID-19 in Wales: A retrospective cohort study. (2023)
Attributed to:
Blood-brain barrier dysfunction and risk of dementia following blood-stream infections
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jinf.2023.02.012
PubMed Identifier: 36773891
Publication URI: http://europepmc.org/abstract/MED/36773891
Type: Journal Article/Review
Volume: 86
Parent Publication: The Journal of infection
Issue: 4
ISSN: 0163-4453